Skip to main content

Table 1 Summary of characteristics of patients with B-ALL

From: A panel of glycoproteins as candidate biomarkers for early diagnosis and treatment evaluation of B-cell acute lymphoblastic leukemia

Code Assigned

Gender

Age at Diagnosis

FAB Classification

Immunophenotypical Classification

Karyotype

Risk Group

MRD

Treatment Outcome

P1

M

3

L1

Common

Absence of metaphases

LR

_

CR

P2

F

3

L1

Pre-B

Absence of metaphases

LR

_

CR

P3

F

5

L1

Common

56,XX,+X,+4,+6,+8,+10,+11,+14,+17,+21,+mar/46,XX

LR

_

CR

P4

M

2

L1

Common

46,XY

LR

_

CR

P5

F

2

L1

Common

46,XX

LR

_

CR

P6

F

3

L1

Common

54,XX,+X,+6,+15,+15,+17,+18,+21,+21/46,XX

LR

_

CR

P7

F

5

L1

Common

47,XY,+21 c

LR

_

CR

P8

M

6

L1

Common

Absence of metaphases

LR

_

CR

P9

F

5

L1

Pre-B

46, XX

LR

_

CR

P10

M

3

L1

Pre-B

46,XY

LR

_

CR

  1. Code: Internal register assigned for the study; M Male, F Female, LR Low Risk, MRD Minimum Residual Disease, CR Complete remission